clinical trial · NCT07601516
Real World Effectiveness and Safety of Deutetrabenazine in Adult Chinese Patients With Huntington's Disease (HD) Chorea in China
Teva Branded Pharmaceutical Products R&D LLC·phase4·completed·n = 50
Huntington's DiseaseChoreaDeutetrabenazine
brief summary
The Primary Objective: To evaluate the real-world effectiveness of deutetrabenazine in adult patients with chorea associated with Huntington's disease in China. The Secondary Objectives: To evaluate the real-world safety of deutetrabenazine in adult patients with chorea associated with Huntington's disease in China.
started
Feb 2, 2024
primary completion
Oct 24, 2025
completion
Oct 24, 2025
last updated
Jun 9, 2026
official title
Real World Effectiveness and Safety of Deutetrabenazine in Chinese Patients With Huntington's Disease (HD) Chorea
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol